Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel A Behr

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
The Journal of Allergy and Clinical Immunology|November 2, 2015
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-CanadiansChristina Gavino, Nancy Hamel, Ji Bin Zeng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2020
Molecular Epidemiology of Mycobacterium tuberculosis To Describe the Transmission Dynamics Among Inuit Residing in Iqaluit Nunavut Using Whole-Genome SequencingGonzalo G Alvarez, Alice A Zwerling, Carla Duncan, et al.
The Journal of Infectious Diseases|August 27, 2024
Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Is Not Suggestive of Health Care-Associated Person-to-Person TransmissionIdowu B Olawoye, Nicholas Waglechner, Fiona McIntosh, et al.
BMJ Open|January 5, 2020
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trialGreg J Fox, Cam Binh Nguyen, Thu Anh Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2025
Virulence hierarchies within the <i>Mycobacterium tuberculosis</i> complexSarah N Danchuk, Shannon C Duffy, Jaryd Sullivan, et al.
Plos One|August 2, 2018
Geospatial distribution of Mycobacterium tuberculosis genotypes in AfricaViolet N Chihota, Antoinette Niehaus, Elizabeth M Streicher, et al.
The Lancet. Microbe|July 10, 2020
Reconsidering <i>Mycobacterium bovis</i> as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance studyShannon C Duffy, Sreenidhi Srinivasan, Megan A Schilling, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
The Lancet Regional Health. Western Pacific|June 3, 2024
Developing best practice public health standards for whole genome sequencing of <i>Mycobacterium tuberculosis</i>Justin T Denholm, Marcel A Behr, Gerard de Vries, et al.
Scientific Reports|October 22, 2015
Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptationsAbdallah M Abdallah, Grant A Hill-Cawthorne, Thomas D Otto, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
The Journal of Allergy and Clinical Immunology|November 2, 2015
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-CanadiansChristina Gavino, Nancy Hamel, Ji Bin Zeng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2020
Molecular Epidemiology of Mycobacterium tuberculosis To Describe the Transmission Dynamics Among Inuit Residing in Iqaluit Nunavut Using Whole-Genome SequencingGonzalo G Alvarez, Alice A Zwerling, Carla Duncan, et al.
The Journal of Infectious Diseases|August 27, 2024
Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Is Not Suggestive of Health Care-Associated Person-to-Person TransmissionIdowu B Olawoye, Nicholas Waglechner, Fiona McIntosh, et al.
BMJ Open|January 5, 2020
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trialGreg J Fox, Cam Binh Nguyen, Thu Anh Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2025
Virulence hierarchies within the <i>Mycobacterium tuberculosis</i> complexSarah N Danchuk, Shannon C Duffy, Jaryd Sullivan, et al.
Plos One|August 2, 2018
Geospatial distribution of Mycobacterium tuberculosis genotypes in AfricaViolet N Chihota, Antoinette Niehaus, Elizabeth M Streicher, et al.
The Lancet. Microbe|July 10, 2020
Reconsidering <i>Mycobacterium bovis</i> as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance studyShannon C Duffy, Sreenidhi Srinivasan, Megan A Schilling, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
The Lancet Regional Health. Western Pacific|June 3, 2024
Developing best practice public health standards for whole genome sequencing of <i>Mycobacterium tuberculosis</i>Justin T Denholm, Marcel A Behr, Gerard de Vries, et al.
Scientific Reports|October 22, 2015
Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptationsAbdallah M Abdallah, Grant A Hill-Cawthorne, Thomas D Otto, et al.
Pageof 21